Bill > HR7845

This bill, the NIH Clinical Trial Diversity Act of 2022, directs the Secretary of Health and Human Services, through the Director of the National Institutes of Health (NIH), to take steps to increase diversity in NIH-funded clinical trials. The key provisions include requiring sponsors of such trials to set clear and measurable goals for recruiting and retaining participants that reflect the demographics of the patient population or the general U.S. population, and to submit detailed plans on how they will achieve these goals. The bill also requires the sharing of participant demographic data, education and training of researchers on diversity, and remediation efforts if goals are not met. Additionally, the bill calls for a study on removing cost barriers to participation and a public awareness campaign to encourage diverse enrollment in clinical trials.

Business and Industry, Health and Social Services

https://www.congress.gov/bill/117th-congress/house-bill/7845/all-info